SCHEMBL17500098

SCHEMBL17500098

CC(O)c1ccn(C2CC(NC(=O)O)C2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HTR3E A5X5Y0 2/20 0.33
▸ HTR3B O95264 2/20 0.33
▸ HTR3A P46098 2/20 0.33
▸ HTR3D Q70Z44 2/20 0.33
▸ HTR3C Q8WXA8 2/20 0.33
▸ SLC22A2 O15244 1/20 0.33
▸ CHRNB2 P17787 1/20 0.33
▸ CHRNA3 P32297 1/20 0.33
▸ CHRNA4 P43681 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SLC47A1 Q96FL8 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17926664 1.00 ALDH1A1 (0.34) ALDH1A1CYP3A4TSHRMAPK1HSD17B10
SCHEMBL17500096 1.00 ALDH1A1 (0.34) ALDH1A1CYP3A4TSHRMAPK1HSD17B10
SCHEMBL17374546 0.78 NPC1 (0.55) ALDH1A1TSHRMEN1KMT2A
SCHEMBL17374263 0.77 CCNT1 (0.32) CCNT1CDK4CCND1CDK9
SCHEMBL17374264 0.77 CCNT1 (0.32) CCNT1CDK4CCND1CDK9
SCHEMBL17500110 0.75 ATM (0.33) ALDH1A1MEN1KMT2AHTR3EHTR3B
SCHEMBL17500111 0.75 ATM (0.33) ALDH1A1MEN1KMT2AHTR3EHTR3B
SCHEMBL21492118 0.74 MAPT (0.38) ALDH1A1MAPK1MEN1KMT2AHTR3A
SCHEMBL17874277 0.73 PSMB8 (0.35) MEN1KMT2AHTR3AL3MBTL1HTR4
SCHEMBL21492216 0.66 MEN1 (0.38) ALDH1A1MAPK1MEN1KMT2ACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040606-A1 ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS PROTEOSTASIS THERAPEUTICS, INC. (US) 2017-03-09 — — WO disclosed
WO-2016115090-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-07-21 — — WO disclosed
WO-2015196071-A9 COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-02-18 — — WO disclosed
Send feedback